13F HOLDINGS REPORT
Athyrium Capital Management, LP
Quarter ended Q1 2024 · Filed May 16, 2024 · Accession 0001123292-24-000137
Total Value
$72.8M
Positions
3
Other Managers
0
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Omeros Corp | OMER | 72,979,000 | $54.1M | 74.33% |
| 2 | Biora Therapeutics Inc. | 74319F305 | 10,929,762 | $12.0M | 16.52% |
| 3 | PUMA BIOTECHNOLOGY INC | PBYI | 1,256,411 | $6.7M | 9.15% |